Medicare ACO

ACO Name and Location

Health Connect Partners, LLC
800 Fifth Ave. Suite 1200
Seattle, WA, 98104

Primary Contact Name

Smitha Dante

Primary Contact Phone Number

425-525-5484

Primary Contact Email Address

Smitha.Dante2@providence.org

Organizational Information:

ACO participants:

ACO Participants

ACO Participant in Joint Venture (Enter Y or N)

COLUMBIA MEDICAL ASSOCIATES, L.L.C.

N

Swedish Edmonds

N

Providence Health & Services- Washington

N

St Joseph Heritage Healthcare

N

PACMED CLINICS

N

Providence St Joseph Medical Center

N

PROVIDENCE PHYSICIAN SERVICES CO

N

Swedish Health Services

N

ACO governing body:

Member

Member's Voting Power

Membership Type

ACO Participant TIN Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

Sadagopan

Deepak

ACO Chief Executive Officer

1

Other: ACO Chief Executive Officer

Providence Health & Services - Washington

Ludwig

Rick

ACO Chief Medical Officer

1

Other: Chief Medical Officer

Providence Health & Services – Washington

Younger

Jon

VP MD Primary Care Physician Services

1

Other: VP MD Primary Care Physician Services

Swedish - Washington

Bela

Biro

Administrative Director Accountable Care Services

1

ACO Participant Representative

Swedish

Martin

James

Medical Director and Associate CMO

1

ACO Participant Representative

Swedish

Yetman

Thomas

Chief Executive Providence Physician Group

1

ACO Participant Representative

Providence Health & Services – Washington

Emaus

Rik

Chief Executive Providence Physician Group

1

ACO Participant Representative

Providence Health & Services – Washington

Johnston

Harold

Chief Executive Providence Medical Group Alaska

1

ACO Participant Representative

Providence Health & Services – Alaska

Stanford

Kelly

Vice President of Clinical Operations and Market Integration for Group Health Cooperative and President of Care Unity

1

ACO Participant Representative

Columbia Medial Group

Rowbotham

Kirk

Chief Medical Officer Physician Management Group, Spokane

1

ACO Participant Representative

Providence Health & Services – Washington

Davidson

Timoth

Chief Executive Physician

1

ACO Participant Representative

Providence Health & Services – Washington

Combs

Scott

Chief Financial Officer Pacifc Medical Centers

1

ACO Participant Representative

Pacific Medical Centers

Mokrohisky

Christy

VP Population Health Management St. Joseph Heritage Health

1

ACO Participant Representative

St. Joseph Heritage Health

Rogers

Terry

Medicare Beneficiary Representative, CEO for the Foundation for Health Care Quality

1

Medicare Beneficiary Representative

 

Medicare Beneficiary Representative

 

Key ACO clinical and administrative leadership:

Deepak Sadagopan

ACO Executive

William Ludwig

Medical Director

Smitha Dante

Compliance Officer

Amy Brittan

Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name

Committee Leader Name and Position

Model of Care Committee

Rick Ludwig, MD – Chair

Operations, Analytics & Compliance Committee

Smitha Dante – Chair

Governing Body Compliance Committee

Smitha Dante - Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Partnerships or joint venture arrangements between hospitals and ACO professionals
  • Hospital employing ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

First Agreement Period

  • Performance Year 2016, $0
  • Performance Year 2015, $0
  • Performance Year 2014, $0

Shared Savings Distribution

First Agreement Period

Performance Year 2016

  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A

Performance Year 2015

  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A

Performance Year 2014

  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2016 Quality Performance Results:

ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

82.31

79.9

ACO-2

CAHPS: How Well Your Providers Communicate

92.71

92.63

ACO-3

CAHPS: Patients' Rating of Provider

91.77

91.93

ACO-4

CAHPS: Access to Specialists

80.6

83.52

ACO-5

CAHPS: Health Promotion and Education

60.94

60

ACO-6

CAHPS: Shared Decision Making

75.82

75.28

ACO-7

CAHPS: Health Status/Functional Status

70.05

71.82

ACO-34

CAHPS: Stewardship of Patient Resources

26.59

27.52

ACO-8

Risk-Standardized, All Condition Readmission

13.37

14.7

ACO-35

Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)

14.73

18.17

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

46.15

53.2

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

67.33

75.23

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

52.93

59.81

ACO-9

Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

5.1

9.27

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 )

13.12

14.53

ACO-11

Percent of PCPs who Successfully Meet Meaningful Use Requirements

99.26

82.72

ACO-39

Documentation of Current Medications in the Medical Record

92.05

87.54

ACO-13

Falls: Screening for Future Fall Risk

50.87

64.04

ACO-14

Preventive Care and Screening: Influenza Immunization

73.35

68.32

ACO-15

Pneumonia Vaccination Status for Older Adults

83.38

69.21

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up

48.34

74.45

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

95.06

90.98

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

50.16

53.63

ACO-19

Colorectal Cancer Screening

71.3

61.52

ACO-20

Breast Cancer Screening

69.72

67.61

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented

62.55

76.84

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

82.04

77.72

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

15.34

18.24

ACO-41

Diabetes: Eye Exam

61.06

44.94

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

70.22

70.52

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

93.71

85.05

ACO-31

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

97.99

88.67

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

89.38

79.67

 

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for “Health Connect Partners, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A17898 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.